Condition: Chronic Lymphocytic Leukemia · Non-Hodgkin Lymphoma · Sponsor: Eli Lilly and Company
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study LOXO-BTK-18001/J2N-OX-JZNA. Participants in the originator study will have the opportunity to continue their assigned study intervention or continue their follow-up visits by transitioning to this study. This study will evaluate the long-term safety and efficacy of pirtobrutinib.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
| Florida Cancer Specialists | Sarasota, Florida, United States | Recruiting |
| The Emory Clinic | Atlanta, Georgia, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic- Minnesota | Rochester, Minnesota, United States | Recruiting |
| University Of Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
| Cayuga Cancer Center | Ithaca, New York, United States | Active Not Recruiting |
| Northwell Health | Lake Success, New York, United States | Recruiting |
| Memorial Sloan-Kettering Cancer Center (MSKCC) - New York | New York, New York, United States | Recruiting |
| Memorial Sloan-Kettering Cancer Center (MSKCC) - New York | New York, New York, United States | Active Not Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06876662